Research · Georgetown
Georgetown co-leads an up-to-$51.7 million ARPA-H protein research effort
The four-year SEEDS consortium will combine physics-guided AI, computational modeling, and laboratory experiments to study harmful protein changes linked to neurodegenerative disease and cancer.
Confirmed facts
Georgetown University and the Buck Institute for Research on Aging co-lead SEEDS, a four-year research consortium supported by an ARPA-H award of up to $51.7 million. The team brings together 10 academic institutions and seven industry partners.
Georgetown’s INTREPID team, led by Priyanka Joshi, will combine experimental measurements, computation, and artificial intelligence to examine how protein sequence and cellular environment affect intrinsically disordered proteins. Initial research will focus on tau and EWS::FLI1, proteins implicated in Alzheimer’s disease and Ewing sarcoma.
Evidence boundary
The announced amount is the maximum award for the full consortium, not Georgetown’s confirmed share. The source describes research goals and expected applications, not demonstrated diagnostic or treatment outcomes. It does not connect SEEDS to Georgetown’s university-wide AI initiative.